Portal de Periódicos da CAPES

Molecular Characterization of Interleukin 2

1982; Wiley; Volume: 63; Issue: 1 Linguagem: Inglês

10.1111/j.1600-065x.1982.tb00415.x

1600-065X

Steven Gillis, Diane Y. Mochizuki, Paul Conlon, Steven H. Hefeneider, Carol A. Ramthun, Anne E. Gillis, Mark Barton Frank, Christopher S. Henney, James D. Watson,

T-cell and B-cell Immunology

Immunological ReviewsVolume 63, Issue 1 p. 167-209 Molecular Characterization of Interleukin 2 Steven Gillis, Steven Gillis Program in Basic Immunology, Fred Hutchinson Cancer Research Center, Seattle, Washington 98104, U.S.A.; the Department of Microbiology. University of California at Irvine, Irvine, California 92717, U.S.A.; and the Department of Pathology, Auckland University Medical School, Auckland, New Zealand.Search for more papers by this authorDiane Y. Mochizuki, Diane Y. Mochizuki Program in Basic Immunology, Fred Hutchinson Cancer Research Center, Seattle, Washington 98104, U.S.A.; the Department of Microbiology. University of California at Irvine, Irvine, California 92717, U.S.A.; and the Department of Pathology, Auckland University Medical School, Auckland, New Zealand.Search for more papers by this authorPaul J. Conlon, Paul J. Conlon Program in Basic Immunology, Fred Hutchinson Cancer Research Center, Seattle, Washington 98104, U.S.A.; the Department of Microbiology. University of California at Irvine, Irvine, California 92717, U.S.A.; and the Department of Pathology, Auckland University Medical School, Auckland, New Zealand.Search for more papers by this authorSteven H. Hefeneider, Steven H. Hefeneider Program in Basic Immunology, Fred Hutchinson Cancer Research Center, Seattle, Washington 98104, U.S.A.; the Department of Microbiology. University of California at Irvine, Irvine, California 92717, U.S.A.; and the Department of Pathology, Auckland University Medical School, Auckland, New Zealand.Search for more papers by this authorCarol A. Ramthun, Carol A. Ramthun Program in Basic Immunology, Fred Hutchinson Cancer Research Center, Seattle, Washington 98104, U.S.A.; the Department of Microbiology. University of California at Irvine, Irvine, California 92717, U.S.A.; and the Department of Pathology, Auckland University Medical School, Auckland, New Zealand.Search for more papers by this authorAnne E. Gillis, Anne E. Gillis Program in Basic Immunology, Fred Hutchinson Cancer Research Center, Seattle, Washington 98104, U.S.A.; the Department of Microbiology. University of California at Irvine, Irvine, California 92717, U.S.A.; and the Department of Pathology, Auckland University Medical School, Auckland, New Zealand.Search for more papers by this authorMark B. Frank, Mark B. Frank Program in Basic Immunology, Fred Hutchinson Cancer Research Center, Seattle, Washington 98104, U.S.A.; the Department of Microbiology. University of California at Irvine, Irvine, California 92717, U.S.A.; and the Department of Pathology, Auckland University Medical School, Auckland, New Zealand.Search for more papers by this authorChristopher S. Henney, Christopher S. Henney Program in Basic Immunology, Fred Hutchinson Cancer Research Center, Seattle, Washington 98104, U.S.A.; the Department of Microbiology. University of California at Irvine, Irvine, California 92717, U.S.A.; and the Department of Pathology, Auckland University Medical School, Auckland, New Zealand.Search for more papers by this authorJames D. Watson, James D. Watson Program in Basic Immunology, Fred Hutchinson Cancer Research Center, Seattle, Washington 98104, U.S.A.; the Department of Microbiology. University of California at Irvine, Irvine, California 92717, U.S.A.; and the Department of Pathology, Auckland University Medical School, Auckland, New Zealand.Search for more papers by this author Steven Gillis, Steven Gillis Program in Basic Immunology, Fred Hutchinson Cancer Research Center, Seattle, Washington 98104, U.S.A.; the Department of Microbiology. University of California at Irvine, Irvine, California 92717, U.S.A.; and the Department of Pathology, Auckland University Medical School, Auckland, New Zealand.Search for more papers by this authorDiane Y. Mochizuki, Diane Y. Mochizuki Program in Basic Immunology, Fred Hutchinson Cancer Research Center, Seattle, Washington 98104, U.S.A.; the Department of Microbiology. University of California at Irvine, Irvine, California 92717, U.S.A.; and the Department of Pathology, Auckland University Medical School, Auckland, New Zealand.Search for more papers by this authorPaul J. Conlon, Paul J. Conlon Program in Basic Immunology, Fred Hutchinson Cancer Research Center, Seattle, Washington 98104, U.S.A.; the Department of Microbiology. University of California at Irvine, Irvine, California 92717, U.S.A.; and the Department of Pathology, Auckland University Medical School, Auckland, New Zealand.Search for more papers by this authorSteven H. Hefeneider, Steven H. Hefeneider Program in Basic Immunology, Fred Hutchinson Cancer Research Center, Seattle, Washington 98104, U.S.A.; the Department of Microbiology. University of California at Irvine, Irvine, California 92717, U.S.A.; and the Department of Pathology, Auckland University Medical School, Auckland, New Zealand.Search for more papers by this authorCarol A. Ramthun, Carol A. Ramthun Program in Basic Immunology, Fred Hutchinson Cancer Research Center, Seattle, Washington 98104, U.S.A.; the Department of Microbiology. University of California at Irvine, Irvine, California 92717, U.S.A.; and the Department of Pathology, Auckland University Medical School, Auckland, New Zealand.Search for more papers by this authorAnne E. Gillis, Anne E. Gillis Program in Basic Immunology, Fred Hutchinson Cancer Research Center, Seattle, Washington 98104, U.S.A.; the Department of Microbiology. University of California at Irvine, Irvine, California 92717, U.S.A.; and the Department of Pathology, Auckland University Medical School, Auckland, New Zealand.Search for more papers by this authorMark B. Frank, Mark B. Frank Program in Basic Immunology, Fred Hutchinson Cancer Research Center, Seattle, Washington 98104, U.S.A.; the Department of Microbiology. University of California at Irvine, Irvine, California 92717, U.S.A.; and the Department of Pathology, Auckland University Medical School, Auckland, New Zealand.Search for more papers by this authorChristopher S. Henney, Christopher S. Henney Program in Basic Immunology, Fred Hutchinson Cancer Research Center, Seattle, Washington 98104, U.S.A.; the Department of Microbiology. University of California at Irvine, Irvine, California 92717, U.S.A.; and the Department of Pathology, Auckland University Medical School, Auckland, New Zealand.Search for more papers by this authorJames D. Watson, James D. Watson Program in Basic Immunology, Fred Hutchinson Cancer Research Center, Seattle, Washington 98104, U.S.A.; the Department of Microbiology. University of California at Irvine, Irvine, California 92717, U.S.A.; and the Department of Pathology, Auckland University Medical School, Auckland, New Zealand.Search for more papers by this author First published: April 1982 https://doi.org/10.1111/j.1600-065X.1982.tb00415.xCitations: 109AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References Aarden, L. A., Burnner, T. K., Cerottini, J. C, Dayer, J. M., De Week, A. L., Dinarello, C. A., Di Sabato, G., Farrar, J. J., Gery, I., Gillis, S., Handsclititnacher, R. E., Henney, C. S., Hoffmann, M. K., Koopman, W. J., Karane, S. M., Lachman, L. B., Lefkowit, S. I., Mishell, R. I., Mizel, S. B., Oppenheim, J. J., Paetkau, V., Plate, J., Rollinghoff, M., Rosenstreich, D., Rosenthal, A. S., Rosenwasser, L. J., Schimpl, A., Shin, H. S. Simon, P. L., Smith, K. A., Wagner, H., Watson, J. D., Wecker, E. & Wood, D. D. (1979) Letter to the Editor. Revised nomenclature for antigen non-specific T cell proliferation and helper factors. J. Immunol. 123. Bonnard, G. D., Yasaka, K. & Jacobson, D. (1979) Ligand-activated T cell growth factor-induced proliferation: Absorption of T cell growth factor by activated T cells. J Immunol. 123, 2704. Caplan, B., Gibbs, C. & Paetkau, V. (1981) Properties of sodium dodecyl sulfate-denalure Interleukin 2. J. Immunol. 126, 1351. Conlon, P. J., Hefeneider, S. H., Henney, C. S. & Gillis, S. (1981) The effects of Interleukin 2 on primary in vivo immune responses. In Immunotherapy of T cell lines, ed. A. E. Fefer Raven Press, (in press). Coutinho, A., Larsson, E.-L., Gronuik, K.-D, & Andersson, J. (1979) Studies on T lymphocyte activation IL The target cells for concanavalian A-induced growth factors. Eur. J. Immunol. 9, 587. Durdik, J., Beck, B. N., Clark, E. A. & Henney, C. S. (1980) Characterization of a lymphoma cell variant selectively resistant to natural killer cells. J. Immunol. 123, 263. Farrar, W. L., Johnson, H. M, & Farrar, J. J. (1981) Regulation of the production of immune interferon and cytotoxic T lymphocytes by Interleukin 2. J. Immunol. 126, 1120. Farrar, J. J., Simon, P. L., Farrar, W. L., Koopman, J. & Fuller-Bonar, J. (1980) Role of mitogen factor, lymphocyte activating factor and immune interferon in the induction of humoral and cell mediated immunity. Ann. N. Y. Acad Sci. 332, 303. Farrar, J. J., Simon, P. L., Koopman, W. J. & Fuller-Bonar, J. (1978) Biochemical relationship of thymocyte mitogenic factor and factors enhancing humoral and cell-mediated immune responses. J. Immunol. 121, 1353. Frank, M. B., Mochizuki, D. Y. Watson, T. & Gillis, S. (1981) Biochemical and Biological characterization of lymphocyte regulatory molecules. VIII. Purification of Interleukin 2 from a Human leukemia T-cell line. J. Immunol. 127, 2361. Gillis, S., Baker, P. E., Ruscetti, F. W. & Smith, K. A. (1978a) Long-term culture of human antigen-specific cytotoxic T cell lines. J. exp. Med 148, 1093. Gillis, S., Ferm, M. M., Ou, W. & Smith, K. A. (1978b) T cell growth factor: parameters of production and a quantitative microassay for activity. J. Immunol. 120, 2027. Gillis, S., Gillis, A. E. & Henney, C. S. (1981) Monoclonal antibody directed against Interleukin 2. I. Inhibition of T-lymphocyte mitogenesis, and the in vitro differentiation of alloreactive cytolytic T-cells. J. exp. Med. 154, 983. Gillis, S. & Henney, C. S. (1981) Biochemical and biological characterization of lymphocyte regulatory molecules. VI. Generation of a B cell hybridoma whose antibody product. Inhibits Interleukin 2 activity. J. Immunol. 126, 1978. Gillis, S. & Mizel, S. B. (1981) T cell lymphoma model for the analysis of Interleukin 1 mediated T-cell activation. Proc. Nat. Acad Sci. 78, 1133. Gillis, S., Scheid, M. & Watson, J. (1980b) Biochemical and biological characterization of lymphocyte regulatory molecules. III. The isolation and phenotypic characterization of Interleukin 2 producing T cell lymphomas. J. Immunol. 125, 2570. Gillis, S. & Smith, K. A. (1977a) Long term culture of tumor-specific cytotoxic T cells. Nature 265, 154. Gillis, S. & Smith, K. A. (1977b) In vitro generation of tumor-specific cytotoxic lymphocytes. Secondary allogeneic mixed tumor-lymphocyte culture of normal murine spleen cells. J. exp. Med 146, 468. Gillis, S., Smith, K. A. & Watson, J. D. (1980a) Biochemical and biological characterization of lymphocyte regulatory molecules. IL Purification of a class of rat and human lymphokines. J. Immunol. 124, 1954. Gillis, S. & Watson, J. (1980) Biochemical and biological characterization of lymphocyte regulatory molecules. V. Identification of an Interleukin 2 producer human leukemia T cell line. J. exp. Med. 152, 1709. Goulmy, E., Blokland, E., van Rood, J., Charmot, D., Malissen, B. & Mawas, C. (1980) Expansion of human lymphocyte populations expressing specific immune response, IV. Human cytotoxic T cell clones against HLA-AI positive males. J. exp. Med. 152, 182. Henney, C. S., Kuribayashi, K., Kern, D. E. & Gillis, S. (1981) Interleukin-2 augments natural killer cell activity. Nature 291, 335. Kuribayashi, K., Gillis, S., Kern, D. E. & Henney, C. S. (1981) Murine NK cell cultures: effects of Interleuk.in-2 and interferon on cell growth and cytotoxic reactivity. J. Immunol. 126, 2321. Kurnick, J. T., Gronvik, K. O., Kirmura, K. A., Lindblom, J. B., Skoog, V. T., Sjoberg, O. & Wigzell, H. (1979) Long-term growth in vitro of human T blasts with maintenance of specificity and function. J. Immunol. 122, 1255. Larsson, E. L., Iscove, N. N. & Coutinho, A. (1980) Two distinct factors are required for induction of T cell growth. Nature (London) 283, 664. Lotze, M. T., Strausser, J. L. & Rosenberg, S. A. (1980) In vitro growth of cytotoxic human lymphocytes. II. Use of T cell growth factor (TCGF) to clone human T cells. J. Immunol. 124, 2972. Maizel, A. L., Mehta, S. R., Ford, R. J. & Lachman, L. B. (1981) Effect of Interleukin 1 on human thymocytes and purified human T cells. J. exp. Med. 153, 470. Minato, N., Reid, L. & Bloom, B. R. (1981) On the heterogeneity of murine natural killer cells. J. exp. Med. 154, 750. Mochizuki, D., Watson, J. & Gillis, S. (1980a) Biochemical and biological characterization of lymphocyte regulatory molecules: IV. Purification of lnterleukin-2 from a murine T cell lymphoma. J. Immunol. 125, 2579. Mochizuki, D. Y., Watson, J. & Gillis, S. (1980b) Biochemical separation ofintcrleukin-2. J. Immunol. Methods 39, 185. Morgan, D. A., Ruscetti, F. W, & Gallo, R. C. (1976) Selective in vitro growth of T lymphocytes from normal human bone marrows. Science 193, 1007. Okada, M. & Henney, C. S. (1980) The differentiation of cytotoxic T cells in vitro II. Amplifying factor(s) produced in primary mixed lymphocyte cultures against K/D stimuli require the presence of Lyt 2 + cells but not Lyt I + cells. J. Immunol. 125, 300. Okada, M., Klimpel, G. R., Kuppers, R. C. & Henney, C. S. (1979) The differentiation of cytotoxic T cells in vitro. I, Amplifying factor(s) in the primary response is Lyt T dependent. J. Immunol 122, 2527. Ruscetti, F. W., Morgan, D. A. & Gallo, R. C. (1977) Functional and morphological characterization of human T cells continuously grown in vitro. J. Immunol. 119, 131. Ruscetti, R. W. & Gallo, R. C. (1981) Human T lymphocyte growth factor: Regulation of growth and function of lymphocytes. Blood 57, 379. Shaw, J., Caplan, B., Paetkau, V., Pilarski, P. L. M., Delovitch, T. L. & McKenzie, I. F. C. (1980) Cellular origins of co-stimulator (IL-2) and Its activity in cytotoxic T lymphocyte responses. J. Immunol. 124, 2231. Smith, K. A., Gillis, S., Baker, P. E., McKenzie, D, & Ruscetti, F. W. (1979) T cell growth factor-mediated T cell proliferation. Proc. M. Y. Acad. Sci. 332, 423. Smith, K. A., Lachmann, L. B., Oppenheim, J. J. & Favata, M. F. (1980) The functional relationship of the interleukins. J. exp. Med. 151, 1551. Strausser, J. L. & Rosenberg, S. A. (1978) In vitro growth of cytotoxic human lymphocytes. I. Growth of cells sensitized in vitro to alloantigens. J. Immunol. 121, 1491. Stull, D. & Gillis, S. (1981) Constitutive production of Interleukin 2 activity by a T cell hybridoma. J. Immunol. 126, 1680. Wagner, H. & Rollinghoff, M. (1978). T-T-cell interaction during in vitro cytotoxic allografts response, I. Soluble products from activated Lyt 1+ T cells trigger autonomously antigen-primed Ly 23′ T cells to cellular proliferation and cytolytic activity. J. exp. Med. 148, 1523. Watson, J. (1979) Continuous proliferation of murine antigen-specific helper T lymphocytes in culture. J. exp. Med. 150, 1510. Watson, J., Gillis, S., Marbrook, J., Mochizuki, D. & Smith, K. A. (1979) Biochemical and biological characterization of lymphocyte regulatory molecules. I. Purification of a class of murine lymphokines. J. exp. Med. 150, 849. Wiley, H. S. & Wallace, R. A. (1981) The structure of vitellogenin. Multiple vitetlogenins in Xenopus laevis give rise to multiple forms of the yolk proteins. J. Biol. Chem. (In press). Young, W. W., Hakomori, S., Durdik, J. M. & Henney, C. S. (1980) Identification of Ganglio-N-Tetraosylceramide as a new cell surface marker for murine natural killer (NK) cells. J. Immunol. 124, 199. Citing Literature Volume63, Issue1April 1982Pages 167-209 ReferencesRelatedInformation